Results 101 to 110 of about 4,520 (170)

Modernising antiviral drug discovery: harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease. [PDF]

In Silico Pharmacol
Msobo A, Maphari PW, Koorsen G, Singab ANB, Mhlongo MI.   +4 more
europepmc   +1 more source

Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server. [PDF]

JMIR Form Res
Yang R, Yin N, Zhang Y, Faiola F.
europepmc   +1 more source

Effectiveness of Nirmatrelvir/Ritonavir in Unvaccinated COVID-19 Patients Treated in the Emergency Department: A Retrospective Propensity-Matched Cohort Analysis. [PDF]

Ther Adv Pulm Crit Care Med
Jehle DVK, Sunesra R, Williams SM, Bilby NJ, Paul KK, Hill K.   +5 more
europepmc   +1 more source

Disparate SARS-CoV-2 Infection Outcomes Abound, but What Makes SARS-CoV-2 Bound for Rebound? [PDF]

J Infect Dis
Sheahan TP.
europepmc   +1 more source

Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases. [PDF]

Virol J
Su G, Gao F, Yang M, Wang L, Liang L, Li S, Li G, Han N, Li G, Qian G, Zhang S, Luo H, Zhang D, Liang H, Ren Z.   +14 more
europepmc   +1 more source

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters. [PDF]

Nano Res
Cui Z, Liu T, Bacon R, Zhao Y, Everitt JI, Yan J, Chen L, Huang J, Wang H, Dong Y, Jin VX, Liu SL, Wang Q.   +12 more
europepmc   +1 more source

Could ChatGPT and co. replace forensic experts? A comparative study on medical liability expertise. [PDF]

Int J Legal Med
Bérar A, Allain JS, Bouvet R.
europepmc   +1 more source

Next-generation inhibitors of SARS-CoV-2 M^pro overcome the deficiencies of Paxlovid. [PDF]

Nat Commun
Luo G, Wang G, Liao C, Zhong B, Fan L, Zhang J, Rao J, Zhang J, Wang Z, Luo M, Yan Y, Lu L, Xu W, Wu F, Gao X, Lu W.   +15 more
europepmc   +1 more source

Candexch algorithm-enhanced chemometric determination of a novel anti-COVID-19 therapeutics in plasma and paxlovid formulation using advanced multivariate modeling: a sustainability-centered bioanalytical approach. [PDF]

BMC Chem
Abbas AEF, Talib NFA, Elghobashy MR, Al Kamaly O, Halim MK.   +4 more
europepmc   +1 more source

Computational molecular modeling of Paxlovid binding

, 2022
openaire   +1 more source